- Home
- TVTX vs DRH Comparison
TVTX vs DRH Comparison
Compare TVTX & DRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVTX
- DRH
- Stock Information
- Founded
- TVTX 2008
- DRH 2004
- Country
- TVTX United States
- DRH United States
- Employees
- TVTX N/A
- DRH N/A
- Industry
- TVTX Biotechnology: Pharmaceutical Preparations
- DRH Real Estate Investment Trusts
- Sector
- TVTX Health Care
- DRH Real Estate
- Exchange
- TVTX Nasdaq
- DRH Nasdaq
- Market Cap
- TVTX 1.6B
- DRH 1.8B
- IPO Year
- TVTX N/A
- DRH 2005
- Fundamental
- Price
- TVTX $17.49
- DRH $9.65
- Analyst Decision
- TVTX Buy
- DRH Buy
- Analyst Count
- TVTX 13
- DRH 6
- Target Price
- TVTX $23.46
- DRH $10.38
- AVG Volume (30 Days)
- TVTX 1.1M
- DRH 3.0M
- Earning Date
- TVTX 02-13-2025
- DRH 11-07-2024
- Dividend Yield
- TVTX N/A
- DRH 1.24%
- EPS Growth
- TVTX N/A
- DRH N/A
- EPS
- TVTX N/A
- DRH 0.29
- Revenue
- TVTX $203,447,000.00
- DRH $1,114,379,000.00
- Revenue This Year
- TVTX $62.17
- DRH N/A
- Revenue Next Year
- TVTX $56.38
- DRH $2.29
- P/E Ratio
- TVTX N/A
- DRH $33.83
- Revenue Growth
- TVTX 57.08
- DRH 4.50
- 52 Week Low
- TVTX $5.12
- DRH $7.74
- 52 Week High
- TVTX $20.33
- DRH $10.00
- Technical
- Relative Strength Index (RSI)
- TVTX 39.02
- DRH 63.70
- Support Level
- TVTX $17.27
- DRH $9.57
- Resistance Level
- TVTX $19.20
- DRH $9.82
- Average True Range (ATR)
- TVTX 0.72
- DRH 0.21
- MACD
- TVTX -0.29
- DRH 0.00
- Stochastic Oscillator
- TVTX 3.80
- DRH 65.88
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease.
About DRH Diamondrock Hospitality Company
Diamondrock Hospitality Company is a real estate investment trust that owns lodging properties. Its business is to acquire, own, manage, and renovate full-service hotel properties in the United States. It operates in cities such as Chicago, Boston, New York, Denver, and others. Within DiamondRock's holdings, the majority of the hotel brands include Marriott, Starwood, and Hilton. The revenue is divided between room, food and beverage, and others. The room segment contributes the majority of the revenue. The firm's customers include leisure transient, business transient, and group customers.